Where I see patients (2)
My reviews
Selected research
-
Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer.
Frontiers in oncology
-
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers.
Urologic oncology
-
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.
Cancer research
Contact me
- Request appointment
- Refer a patient
- (415) 476-4616
5.0